Home/Filings/4/0001214659-25-009123
4//SEC Filing

Krop Julie 4

Accession 0001214659-25-009123

CIK 0001398733other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 1:59 PM ET

Size

5.6 KB

Accession

0001214659-25-009123

Insider Transaction Report

Form 4
Period: 2025-06-11
Krop Julie
Director
Transactions
  • Award

    Stock Option (Right to Purchase)

    2025-06-11$3.41/sh+42,000$143,22042,000 total
    Exercise: $3.41From: 2026-06-11Exp: 2035-06-11Common Stock (42,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001643127

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 1:59 PM ET
Size
5.6 KB